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Abstract
Background: Cholecystectomy, gold standard treatment for gallbladder lithiasis, is closely associated with
increased bile reflux into the stomach as amply demonstrated by experimental studies. The high prevalence of
gallstones in the population and the consequent widespread use of surgical removal of the gallbladder require an
assessment of the relationship between cholecystectomy and gastric mucosal disorders.
Morphological evaluations performed on serial pre and post – surgical biopsies have provided new acquisitions
about gastric damage induced by bile in the organ.
Methods: 62 elderly patients with gallstone related disease were recruited in a 30 months period. All patients were
subjected to the most appropriate treatment (Laparoscopic cholecystectomy). The subjects had a pre-surgical
evaluation with:
• dyspeptic symptoms questionnaire,
• gastric endoscopy with body, antrum, and fundus random biopsies,
• histo-pathological analysis of samples and elaboration of bile reflux index (BRI).
The same evaluation was repeated at a 6 months follow-up.
Results: In our series the duodeno-gastric reflux and the consensual biliary gastritis, assessed histologically with the
BRI, was found in 58% of the patients after 6 months from cholecystectomy. The demonstrated bile reflux had no
effect on H. pylori’s gastric colonization nor on the induction of gastric precancerous lesions.
Conclusions: Cholecystectomy, gold standard treatment for gallstone-related diseases, is practiced in a high
percentage of patients with this condition. Such procedure, considered by many harmless, was, in our study,
associated with a significant risk of developing biliary gastritis after 6 months during the postoperative period.
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Background
A thorough review of literature has shown that chole-
cystectomy is accompanied, in the years following sur-
gery, by an increase in duodenal-gastric reflux (DGR)
[1-3], however, there is only partial data on the inci-
dence of bile reflux gastritis in patients undergoing
cholecystectomy [4-7].
Numerous studies have also shown an association
between cholecystectomy and gastric cancer [8-12]; the
increased bile reflux may be a determining factor, if this
risk was confirmed.
It is common, in patients who undergo cholecystectomy,
to observe a persistence of upper abdominal symptoms
often labeled as post-cholecystectomy syndrome [3,13-17];
these symptoms are likely related to a post-surgical duode-
nal-gastric reflux.
There are still conflicting reports on the possible
effects of duodenal-gastric reflux on Helicobacter
pylori’s gastric infection.
We therefore decided to perform a prospective study on
elderly patients which refer to our general surgery depart-
ment in order to evaluate whether cholecystectomy
increases the risk of gastritis, induces the onset of dyspep-
tic symptoms, alters the incidence of H. pylori infection or
increases the risk of gastric cancer.
Methods
The primary objective of our study was to evaluate the
incidence of postoperative biliary gastritis through the pro-
spective evaluation of patients with symptomatic gallblad-
der lithiasis treated with laparoscopic cholecystectomy.
Among the secondary objectives were:
- Assessment of changes in prevalence of H. pylori
gastritis resulting from the eventual bile reflux gastritis
- Assessment of the presence of lesions, in the follow-
up, considered as risk factors for gastric cancer
The study was carried out with the following modalities:
1) recruitment of elderly patients (over 70) with symp-
tomatic gallstones and ultrasound documentation of the
stones for which there was indication for cholecystect-
omy and who gave informed consent for the study
participation.
2) exclusion of all patients exposed to other risk fac-
tors such as NSAIDs or alcohol who are able to deter-
mine gastric symptoms and / or reactive gastritis.
3) pre-surgical evaluation:
• dyspeptic symptoms questionnaire subministration
(Table 1),
• gastric endoscopy in order to assess the absence of
macroscopically visible lesions and to provide multiple
biopsies of the gastric antrum, body and fundus,
• histo-pathological analysis of samples and elabora-
tion of bile reflux index (BRI). This index is elaborated
grading the following four histological parameters on a
scale from 0 to 3: lamina propria edema (Oed), chronic
inflammation (CI), intestinal metaplasia (IM), Helicobac-
ter pylori colonization density (Hp). Subsequently the
following formula is applied to obtain the BRI:(7xOed)
+ (3xIM) + (4xCI) - (6xHp).
A value of BRI equal to or greater than 14 is indica-
tive of reflux gastritis and if used as a single diagnostic
investigation for pathological DGR has a sensitivity of
70% and a specificity of ‘85% to detect a bile level > 1.00
mmol / L in the stomach (upper limit of physiological
bile reflux) [18-20]. Patients that may be positive for H.
pylori should not perform eradication therapy at least
until the first follow-up at 6 months.
4) laparoscopic cholecystectomy.
5) clinical reassessment of patients at 6 months post-
operatively with the dyspeptic symptoms questionnaire
and new endoscopy for BRI score evaluation.
6) Comparison of clinical and histopathological data
obtained during pre-surgical phase and during follow-up
at 6 months.
The study has provided so far, since January 2010, the
enrollment of 62 patients. Of these, 31 completed the
follow-up to 6 months, 19 were lost at follow-up, 12
patients have yet to complete the follow-up. Nineteen of
62 patients (30.64%) did not return for the post-opera-
tive follow-up ,maybe for the scant willingness to
undergo an invasive follow-up endoscopy, especially if
the purpose is the finding of a bile reflux gastritis, a
condition that can occur without symptoms and who’s
long term risks are unknown. Patients who did not
undergo the postoperative examination were excluded
from the study.
Results and discussion
Of the 31 patients who completed follow-up (50%), 13
were men and 18 women. The age was between 70 and
85 years with an overall mean age of 74.86. The age
range in the male group was between 71 and 85 years
with a mean age of 75.09 years. In female subjects the
minimum age was 70 years and the maximum age was
80 years, with an average of 74.70 years.
Table 1 Dyspeptic symptoms questionnaire
Symptom Pre-operative
score(0-3)
Post-operative
score(0-3)
Epigastric pain
Nausea
Bilious vomiting
Upper abdominal quadrant swelling
Post-prandial fullness
Heartburn
Frequent belching
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The clinical evaluation showed, in pre-operative phase,
in all cases, the presence of dyspeptic symptoms. How-
ever we must remember that symptoms such as upper
abdominal pain, nausea and bilious vomiting are also
attributable to episodes of “biliary colic” related to the
gallstone disease.
However, it results difficult to attach any dyspeptic
symptom found to a possible pathological DGR present
in the pre-surgical phase and to its associated morpho-
logical changes cause in 23 of 31 examined subjects a
coexisting H. pylori infection could have been responsi-
ble for similar symptoms.
The persistence in some subjects (13 of total 31 exam-
ined), after surgical removal of the gallbladder, of the pre-
vious symptoms could, on the other hand, be related to
the onset of a pathological DGR and the associated mor-
phological changes. However, resulting the H.pylori infec-
tion prevalence unchanged , it remains difficult, based on
clinical observations, to attribute these symptoms solely to
DGR. Final results would require assessments of groups of
subjects negative for Helicobacter pylori infection that we
have chosen not to follow exclusively to evaluate the in
vivo effect of bile acid levels on the H. pylori infection in
subjects after cholecystectomy.
Preoperative histo-pathological findings showed the
following:
Of the 31 patients examined 23 were positive for Helico-
bacter pylori infection in pre-operative and in all these
subjects the antrum was always affected alone or in the
context of a pan-gastritis. The infection was associated
with morphological features of a mild or moderate chronic
gastritis.
In all studied subjects , even in H. pylori negative areas,
chronic inflammatory changes were highlighted; such
thing could be explained by an abnormal duodenal-gastric
reflux related to the gallbladder exclusion operated by
lithiasis. In 8 cases these modifications were such that,
also pre-operatively, in one or more portions of the sto-
mach, the BRI exceeded the threshold value of 14.
Since the calculation of the BRI gives a different
weight to the various evaluated morphological entities
and in particular requires the subtraction of the density
of Helicobacter pylori colonization in order to detect the
presence of chronic inflammation related to duodenal-
gastric reflux, it is easy to understand that, although
there is an antrum-body-fundus gradient for the damage
caused by DGR, because the antrum is the most com-
mon site of bacterial colonization, the average BRI value
calculated in this site is going to be lower than that of
the body and of the fundus (Table 2).
In the post-operative phase at 6 months there is an
increase of the mean values of BRI in all patients and in
all portions of the stomach, while the incidence of Heli-
cobacter pylori results unchanged (Table 3 and 4).
As a result,the number of individuals with one or
more locations with a BRI value > 14 increases from 8
subjects in the preoperative phase to 18 patients in the
postoperative one.
This data was statistically tested in order to demonstrate
the existence of an association between the surgical
removal of the gallbladder and the occurrence of bile
reflux gastritis. In first instance we organized a table for
observed frequencies (Table 5). Using the c2 test we com-
pared the observed frequencies with the expected ones if
the two conditions in question were independent.
The value of the c2 obtained from processing our
data, with one degree of freedom, is 5.365 with a
p value of 0.0205, and since the critical value of c2 for
one degree of freedom and with a probability of 5% is 3,
84 is possible to establish with this level of security the
existence of an association between cholecystectomy
and the onset of biliary gastritis.
In our sample there was no finding of intestinal metapla-
sia in either preoperative or postoperative phase. This
result is consistent with the theory that intestinal metapla-
sia, although a precancerous lesion, requires a longer time
(more than six months) to develop.
Conclusions
Cholecystectomy, gold standard treatment for gallstone-
related diseases, is practiced in a high percentage of
patients with this condition. Such procedure, considered
by many harmless, was, in our study, associated with a
significant risk of developing biliary gastritis after 6
months during the postoperative period. This occurrence
was found in our series in 58% of patients who under-
went cholecystectomy (Fig. 1). However, the presence of
symptoms in post-operative timing does not reflect the
histological findings in these same patients: while, in fact,
a positive histological BRI was found in 58% of patients
after cholecystectomy, clinical symptoms were found in
41.9% of them .In addition these symptoms could also be
related to the persistence of H. pylori infection.
Table 2 Pre-operative BRI values.
BRI mean value SD
Antrum 8.5 5.2
Body 10.69 7.06
Fondus 10.15 6.33
Table 3 Post-operative BRI values.
BRI mean value SD
Antrum 15.82 7.83
Body 17.24 7.72
Fondus 16.93 7.48
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Infection by H. pylori detected preoperatively in 23 of 31
patients resulted unchanged at the 6 months post-opera-
tive follow-up. In our series the duodeno-gastric reflux,
assessed histologically with the BRI in 58% of the patients
after cholecystectomy, seems to have no effect or, at least,
no ability to eradicate H. pylori from the gastric mucosa.
Although in our series we have not found the pre-
sence of intestinal metaplasia of the gastric mucosa in
any of the postoperative samples, studies such as the
Swedish study [12] are only partially refuted, and associ-
ate cholecystectomy with an increased incidence of gas-
tric cancer, potentially attributable to chronic
inflammatory insults such as bile reflux gastritis; this
condition is all but uncommon in our series of patients
who undergo cholecystectomy.
Although these findings remain to be confirmed on a
wider coverage, pending further clarification, a clinical
and endoscopic follow-up in relation to the suspected
potential transformation is recommended in patients
who undergo cholecystectomy and in which a chronic
bile reflux gastritis is diagnosed. We planned, therefore,
to continue our experimental investigation for the next
three years, aiming to gather a wider sample of indivi-
duals in order to draw further conclusions.
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